insights_auto
Why is BSLN down 2.59%?
Dive Deeperchevron_right
BSLN:SWX
Basilea Pharmaceutica AG Allschwil
CHFÂ 71.50
arrow_downward
-2.59%(-1.90) 1D
Oct 29, 5:30:41 PM GMT+1 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BSLN...
Open
CHFÂ 73.60
High
CHFÂ 74.00
Low
CHFÂ 71.40
Mkt. cap
961.15M
Avg. vol.
34.99K
Volume
25.48K
P/E ratio
18.66
52-wk high
CHFÂ 75.80
52-wk low
CHFÂ 44.70
EPS
CHFÂ 3.83
Shares outstanding
13.44M
No. of employees
200
Open
CHFÂ 73.60
High
CHFÂ 74.00
Low
CHFÂ 71.40
Mkt. cap
961.15M
Avg. vol.
34.99K
Volume
25.48K
P/E ratio
18.66
52-wk high
CHFÂ 75.80
52-wk low
CHFÂ 44.70
EPS
CHFÂ 3.83
Shares outstanding
13.44M
No. of employees
200
News stories
From web sources and news partners
bloomingbit
·
16 minutes ago
U.S. Stocks Turn Lower; Nasdaq Drops 1.72%
PPC Land
·
1 hour ago
Focus Media Network revenue gains 104% ahead of $25m Nasdaq IPO
finchannel
·
38 minutes ago
Nasdaq: Why Companies Are Choosing Us
Profile
Basilea Pharmaceutica is a biopharmaceutical company based in Allschwil near Basel, Switzerland. Basilea was spun off from F. Hoffmann-La Roche in 2000 and has been listed as an independent company on the Swiss stock exchange since March 2004. The company's subsidiary is Basilea Pharmaceutica International AG, Allschwil, which is also based in Allschwil, Switzerland, and in which the company's operating activities are bundled. Wikipedia
About Basilea Pharmaceutica AG Allschwil